APA (7th ed.) Citation

RG, K., EM, v. L., M, W., AJ, v. d. K., KA, G., D, H., . . . J, R. (2023). Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. Journal of autoimmunity, 139, 103081. https://doi.org/10.1016/j.jaut.2023.103081

Chicago Style (17th ed.) Citation

RG, Kamperman, et al. "Does COVID-19 Impact the Prevalence of Myositis Specific Antibodies in the Netherlands? A Comparative Nationwide Study." Journal of Autoimmunity 139 (2023): 103081. https://doi.org/10.1016/j.jaut.2023.103081.

MLA (9th ed.) Citation

RG, Kamperman, et al. "Does COVID-19 Impact the Prevalence of Myositis Specific Antibodies in the Netherlands? A Comparative Nationwide Study." Journal of Autoimmunity, vol. 139, 2023, p. 103081, https://doi.org/10.1016/j.jaut.2023.103081.